Replies to post #157065 on Innovation Pharmaceuticals Inc (IPIX)

[tombrady12nh]

5 minimum SS

[sox040713]

If K shows efficacy in P2a, then the breakthrough therapy designation could be in play. That'll shorten the approval time. Dr. B said he plans to start P2a this fall, so I don't know where you got the 6-12 months from.

I still think K counts for at least 1/3 of the current market cap. Had K failed P1, the SP would be under $1 (IMO).

So then we are looking at 5 years given K Phase 2 is 6-12 months (at least) from starting.